News

FTC puts conditions on Sun Pharma’s proposed acquisition of Ranbaxy

FTC puts conditions on Sun Pharma’s proposed acquisition of Ranbaxy

01-02-2015

Indian drugmakers Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories have agreed to divest Ranbaxy’s…

Antibiotics and Infectious diseasesGenericsIndiaLegalMergers & AcquisitionsMinocyclineRanbaxy LaboratoriesSun Pharmaceutical IndustriesTorrent PharmaceuticalsUSA

Medicines for Malaria Venture signs collaboration with Cipla and Strides Arcolab for rectal artesunate

Medicines for Malaria Venture signs collaboration with Cipla and Strides Arcolab for rectal artesunate

27-11-2014

The Medicines for Malaria Venture has signed collaboration agreements with Cipla and Strides Arcolab,…

Antibiotics and Infectious diseasesCiplaIndiaPharmaceuticalResearchStrides Arcolab

Indian industry decries smear campaign against its pharma exporters

Indian industry decries smear campaign against its pharma exporters

26-09-2014

The India Brand Equity Foundation (IBEF), on behalf of the government of India, has taken strong objection…

Antibiotics and Infectious diseasesGenericsIndiaMarkets & MarketingPoliticsProductionUSA

Merck Serono to partner with Lupin for emerging market exposure

Merck Serono to partner with Lupin for emerging market exposure

17-09-2014

Merck Serono, the biotech unit of Germany’s Merck KGaA, has entered a strategic partnership with Indian…

Antibiotics and Infectious diseasesBiotechnologyCardio-vascularDiabetesGermanyIndiaLicensingLupinMerck KGaAMerck Serono

Helperby Therapeutics and Cadila make progress on first antibiotic resistance breaker

Helperby Therapeutics and Cadila make progress on first antibiotic resistance breaker

19-06-2014

Helperby Therapeutics, a spin-out drug discovery company from St George’s University of London, UK,…

Antibiotic resistanceAntibioticsAntibiotics and Infectious diseasesBiotechnologyCadila PharmaceuticalsHelperby TherapeuticsIndiaUK

India urged to take action on unregulated tuberculosis drug sales

23-03-2014

Although cases of tuberculosis are dropping in Europe, as is the incidence in the USA, an extremely slower…

Antibiotics and Infectious diseasesAsia-PacificHealthcareIndiaPharmaceuticalResearch

Mylan pushes further into India, introducing critical care segment

Mylan pushes further into India, introducing critical care segment

12-03-2014

US generics major Mylan says its Indian subsidiary has launched a Critical Care segment in India. The…

AmbisomeAntibiotics and Infectious diseasesAsia-PacificGenericsIndiaMarkets & MarketingMylan Laboratories

COMPANY SPOTLIGHT

Menarini

Back to top